Prot#CORT125134-452: An Open-Label Extension Study of the Safety of Relacorilant (CORT125134) in the Treatment of the Signs and Symptoms of Endogenous Cushing Syndrome

Project: Research project

Project Details

StatusActive
Effective start/end date9/22/20 → 7/31/25

Funding

  • ICON Clinical Research, LLC (CORT125134-452 // CORT125134-452)
  • Corcept Therapeutics Incorporated (CORT125134-452 // CORT125134-452)